Retour sur lavenir.net
   UMICORE 17.600 € (-0,17 %)     EVS BROADC.EQUIPM. 36.550 € (+0,27 %)     SEQUANA MEDICAL 0.522 € (+5,14 %)     XIOR 27.650 € (-0,54 %)     GBL 80.700 € (-0,92 %)     SOFINA 226.000 € (-0,35 %)     BARCO 9.425 € (-3,23 %)     AEDIFICA 73.600 € (-0,81 %)     MELEXIS 65.300 € (+2,75 %)     ACKERMANS V.HAAREN 279.200 € (-0,64 %)     ELIA GROUP 137.900 € (-0,93 %)     AB INBEV 62.580 € (-2,31 %)     AGEAS 68.600 € (+0,88 %)     ARGENX SE 686.400 € (-3,00 %)     KBC ANCORA 78.900 € (-1,00 %)     KINEPOLIS GROUP 30.400 € (+0,66 %)     UNIFIEDPOST GROUP 2.740 € (+3,79 %)     WERELDHAVE BELGIUM 53.600 € (-1,83 %)     BANQUP GROUP 2.740 € (+3,79 %)     SOLVAY 27.360 € (-1,72 %)     BEKAERT 41.850 € (+0,72 %)     HOME INVEST BE. 19.160 € (-1,84 %)     AZELIS GROUP 10.360 € (+0,78 %)     WDP 23.880 € (-1,08 %)     CENERGY 21.160 € (+0,19 %)     DEME GROUP 184.800 € (-0,11 %)     CIE BOIS SAUVAGE 323.000 € (-0,31 %)     CARE PROPERTY INV. 12.820 € (-0,77 %)     SHURGARD 27.850 € (-0,36 %)     BREDERODE 103.600 € (+0,39 %)     OPTION 6.760 € (-3,43 %)     D'IETEREN GROUP 182.700 € (-1,14 %)     AGFA-GEVAERT 0.487 € (-0,51 %)     LOTUS BAKERIES 9 940.000 € (-0,30 %)     VIOHALCO 14.500 € (0,00 %)     GIMV 48.650 € (+0,41 %)     KBC 117.750 € (-0,63 %)     ECONOCOM GROUP 1.485 € (0,00 %)     TESSENDERLO 21.100 € (-0,24 %)     VAN DE VELDE 32.500 € (+0,31 %)     COLRUYT 33.140 € (+0,42 %)     FAGRON 23.800 € (-2,26 %)     JENSEN-GROUP 71.000 € (-0,84 %)     ASCENCIO 50.000 € (-0,79 %)     FLUXYS BELGIUM D 21.500 € (+0,94 %)     UCB 247.100 € (-4,59 %)     RECTICEL 10.020 € (-0,99 %)     TUBIZE-FIN 214.800 € (-3,33 %)     BPOST 1.882 € (-0,84 %)     CMB.TECH 11.260 € (-1,05 %)     VASTNED 30.100 € (+0,17 %)     BIOTALYS 2.285 € (-1,51 %)     DECEUNINCK 2.175 € (+0,69 %)     ONTEX GROUP 3.040 € (-3,34 %)     IMMOBEL 21.600 € (+0,93 %)     MONTEA 72.200 € (-0,96 %)     RETAIL ESTATES 69.800 € (-2,10 %)     IBA 14.400 € (-0,96 %)     TITAN S.A. 46.740 € (-1,72 %)     ONWARD MEDICAL 2.905 € (-2,02 %)  
   ABEO 8.060 € (+1,51 %)     SAFRAN 282.400 € (-6,80 %)     HOPIUM 0.008 € (-2,44 %)     BE SEMICONDUCTOR 227.900 € (+0,40 %)     GENFIT 8.900 € (-2,41 %)     SHELL PLC 37.695 € (+0,24 %)     STMICROELECTRONICS 37.610 € (+0,90 %)     EXOR NV 70.000 € (-0,28 %)     LVMH 486.000 € (-0,93 %)     SANOFI 81.020 € (-1,23 %)     UMG 20.080 € (-1,47 %)     KERING 243.200 € (-2,01 %)     MR BRICOLAGE 4.670 € (-1,68 %)     CARREFOUR 16.710 € (-0,54 %)     AIRBUS 170.520 € (-1,54 %)     AXA 42.420 € (-0,07 %)     FLEURY MICHON 22.300 € (0,00 %)     AALBERTS NV 31.440 € (-0,69 %)     FASTNED 29.800 € (+5,11 %)     TIKEHAU CAPITAL 19.200 € (-2,34 %)     JCDECAUX 19.230 € (-3,42 %)     ATOS 36.240 € (-2,74 %)     NANOBIOTIX 26.340 € (-5,05 %)     SARTORIUS STED BIO 188.500 € (+0,96 %)     LEGRAND 147.750 € (-0,54 %)     SOITEC 100.750 € (+0,75 %)     ARKEMA 61.600 € (-0,65 %)     CSG 21.040 € (-0,82 %)     ACCOR 44.340 € (-2,27 %)     UNIBAIL-RODAMCO-WE 104.750 € (-0,62 %)     ADOCIA 5.720 € (+16,83 %)     AIR FRANCE -KLM 9.896 € (-3,50 %)     BIOMERIEUX 90.600 € (+0,50 %)     ABN AMRO BANK N.V. 30.200 € (+0,33 %)     MANITOU BF 21.750 € (+1,64 %)     BOLLORE 5.080 € (+1,09 %)     CRCAM ILLE-VIL.CCI 116.120 € (+0,66 %)     CTP 16.100 € (-1,35 %)     GROUPE OKWIND 1.200 € (+36,36 %)     BENETEAU 7.100 € (-1,11 %)     ABIVAX 98.000 € (-2,58 %)     BNP PARIBAS ACT.A 92.140 € (-0,50 %)     BASIC-FIT 31.460 € (-0,57 %)     CIECHARGEURSINVEST 8.500 € (0,00 %)     THALES 247.700 € (-5,92 %)     Coca-ColaEuropacif 82.100 € (-1,20 %)     SPIE 46.460 € (-1,27 %)     TECHNIP ENERGIES 39.420 € (-0,15 %)     SCHNEIDER ELECTRIC 272.100 € (-0,55 %)     ING GROEP N.V. 24.495 € (0,00 %)     ALSTOM 17.050 € (-0,20 %)     GECINA 72.400 € (-0,21 %)     EDENRED 20.620 € (+1,53 %)     BOUYGUES 52.200 € (-0,53 %)     UNILEVER 48.705 € (-1,23 %)     REXEL 36.750 € (-1,63 %)     VALEO 11.120 € (-1,20 %)     HEINEKEN 67.660 € (-2,06 %)     L'OREAL 345.150 € (-1,65 %)     ELIS 26.580 € (-0,97 %)  
News Réglementées
21/04/2026 09:00

Original-Research: Semperit AG Holding (von NuWays AG): BUY

Original-Research: Semperit AG Holding - from NuWays AG

21.04.2026 / 09:00 CET/CEST
Dissemination of a Research, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this research. The result of this research does not constitute investment advice or an invitation to conclude certain stock exchange transactions.


Classification of NuWays AG to Semperit AG Holding

Company Name:Semperit AG Holding
ISIN:AT0000785555
 
Reason for the research:Update
Recommendation:BUY
Target price:EUR 21.5
Target price on sight of:12 months
Last rating change:
Analyst:Sarah Hellemann

Semperit beats Q1 26 expectations in preliminary EBITDA;chg.

On Friday, Semperit released its preliminary Q1 EBITDA ahead of its quarterly report publication scheduled for May 13th, signaling a significant beat of expectations. In detail:

Q1 EBITDA soared by approx. 134% yoy to around € 26m, materially ahead of our expectation of a 25% yoy improvement leading to € 13.9m (eNuW). In our opinion, the strong result was driven by three circumstances: Firstly, a weak comparable base: in Q1 25 the company faced a challenging market environment and project delays. Secondly, the company is strengthening its margins through ongoing cost control and its current cost savings program of € 10m annually, of which € 6m were completed in FY 25. Thirdly, we expect the company to have faced continued positive demand momentum, potentially aided by warm weather in February and March driving construction demand.

Our view on material costs. The strong recent performance supports our view that Semperit can absorb short-term raw material price spikes over a 4–6 week period without significant margin impact. Prices for synthetic and natural rubber have started to retreat from recent peaks (-8.3% and -3%) following supply disruptions in Asia and geopolitical tensions linked to the Iran conflict. We expect levels to remain elevated and volatile in Q2, implying potential P&L pressure. In response, the company should seek to pass on raw material inflation through pricing, on which timing and execution remain key.

Raw material prices could normalize from currently unsustainably high levels over the course of the year, offering upside to margins. Material availability appears secure for now, supported by Semperit’s diversified sourcing approach, though ongoing geopolitical uncertainty poses risks. Our operational EBITDA forecast reflects this backdrop, incorporating a 12.2% yoy increase in material expenses.

Looking ahead, the strong preliminary result firmly underlines our view that the FY26 guidance of operational EBITDA of € 95m is achievable. Hence, we raise our revenue estimates to € 724m (eNuW) and our operational EBITDA estimate to € 100m (eNuW), excluding project costs of approx. € 5m (eNuW).

Further operational improvements are expected as the company advances its cost-cutting program, ERP project, and product portfolio reviews. Additional drivers in our view include higher capacity utilization from continued demand strengthening and ongoing price negotiations with customers.

If demand continues to strengthen materially, moving ahead on the company’s ramp-up on production capacities could follow, although exact timing is not quite certain yet at the current stage. This should include finishing preparations on its two extended facilities, which the company largely completed during its cyclical downturn.

Maintaining BUY at a raised PT of € 21.5 (previously € 21.0), based on DCF.
 

You can download the research here: semperit-ag-holding-2026-04-21-update-en-f4473
For additional information visit our website: https://www.nuways-ag.com/research-feed

Contact for questions:
NuWays AG - Equity Research
Web: www.nuways-ag.com
Email: research@nuways-ag.com
LinkedIn: https://www.linkedin.com/company/nuwaysag
Adresse: Mittelweg 16-17, 20148 Hamburg, Germany
++++++++++
Diese Meldung ist keine Anlageberatung oder Aufforderung zum Abschluss bestimmter Börsengeschäfte.
Offenlegung möglicher Interessenkonflikte nach § 85 WpHG beim oben analysierten Unternehmen befindet sich in der vollständigen Analyse.
++++++++++


The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News


2311634  21.04.2026 CET/CEST

Source : Webdisclosure.com

© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière